You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0089: A Two-Stage, Phase Ii, Multi-Center Pilot Study of Intravenous Paclitaxel, Carboplatin, and Bevaci-Zumab Followed By Paclitaxel and Bevacizumab Consolidation Therapy in Patients with Newly Diagnosed Stage Iii/Iv Epithelial Ovarian, Fallopian Tube, …

Citation Tools

Article menu
Download PDFPDF
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0089: A Two-Stage, Phase Ii, Multi-Center Pilot Study of Intravenous Paclitaxel, Carboplatin, and Bevaci-Zumab Followed By Paclitaxel and Bevacizumab Consolidation Therapy in Patients with Newly Diagnosed Stage Iii/Iv Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Micha JP, Goldstein BH, Graham CL, et al
0089: A Two-Stage, Phase Ii, Multi-Center Pilot Study of Intravenous Paclitaxel, Carboplatin, and Bevaci-Zumab Followed By Paclitaxel and Bevacizumab Consolidation Therapy in Patients with Newly Diagnosed Stage Iii/Iv Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
International Journal of Gynecologic Cancer 2006;16:625.